SRF Ltd

- The transcript does not specifically mention any current or planned fundraising through debt or equity. - The company has significant ongoing and planned capital expenditure: approximately INR 2,500 crore planned for FY27 and a major INR 10,000 crore investment plan at the Odisha site over 4-5 years. - There is no explicit discussion of raising funds via debt or equity to finance these investments. - Management focuses on internal funding and operational efficiencies to support growth. - No direct references are made to equity issuance or debt raising during the Q4 & FY26 earnings call.

- INR2,300 crore investment at new Odisha site over next 2 years for fourth-generation refrigerant gases (20,000 MT pa capacity), including backward integration into hydrofluoric acid (30,000 MT) and electronic grade HF. - Capex of ~INR2,500 crore planned for FY27 aligned with long-term growth priorities. - Recent trial runs of KAPLAR plant for capacitor-grade BOPP films to be capitalized shortly. - BOPP-BOPE line expected to commence production in July. - INR180 crore investment in a state-of-the-art BOPA (polyamide) line, operational by September 2027, India's first of its kind. - Commissioning of new dipping line at Manali in Technical Textiles shortly. - Pharma intermediates plant 2 coming up; pipeline of molecules expanding with focus on regulatory starting materials. - Debottlenecking exercise expanding HFC capacity beyond 65,000 MT. - Strategic fluoropolymer investments progressing; Chemours arrangement on track for Q4 revenue ramp-up.

- Chemicals business expected to grow 15-20% in FY27 despite pricing pressures and volatility. - Strong product pipeline across specialty chemicals from intermediates through to AI critical for growth. - Fluoropolymer segment ramp-up anticipated in the latter part of FY27 with high-margin contracts (e.g., Chemours arrangement) starting Q4. - Refrigerant gases (HFOs) capacity expansion underway, targeting commissioning by Feb 2028, with early customer interest and sales ramp-up expected. - Newer chemical products, including pharma and agro intermediates, progressing with expected commercialization and revenue contribution over next 2-3 years. - Exports of aluminum foil specialty grades have begun and are set to improve in 2027. - Continued focus on operational efficiencies and technological interventions to sustain margins and volumes amid pricing normalization.

- SRF Limited expects Chemicals business growth of 15% to 20% in FY27, driven by capacity expansions and product pipeline. - Incremental capacity enhancements in refrigerant gases, including next-generation HFOs (HFO-1234yf, HFO-1234ze, HFO-1233zd), will contribute significantly. - Ramp-up of fluoropolymer specialty grades and fluoropolymer capacity expected in the second half of FY27. - Strong progress on aluminum foil exports and specialty product approvals to drive revenue growth through 2027. - Investments of around INR2,500 crore planned in FY27, going towards BOPP, BOPA lines, specialty chemicals, and more. - Operational efficiencies and technological interventions are expected to sustain competitive margins despite pricing pressures. - Ongoing approvals and commercialization timelines indicate revenue ramp-ups mostly in the second half of FY27 and beyond. - Overall, the company aims to sustain volume growth and margin improvements despite a volatile macro environment.

- The current order book and pending orders were not explicitly quantified in the transcript. - Demand remains strong across key segments, and the company is working to fulfill all existing orders. - There is significant customer interest, especially in fluoropolymers and specialty chemicals. - Capacity expansions and debottlenecking exercises are underway to meet growing orders and expected demand. - Export shipments have started in aluminum, supporting ramp-up in outcomes. - The Chemours arrangement for fluoropolymers is on track with revenue ramp-up expected in Q4 FY26 and accelerating in FY27. - The company is focused on reducing product approval timelines to capitalize on incoming orders rapidly. - While not quantified, order momentum indicates robust near-term and medium-term demand visibility.